BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 28 filers reported holding BICYCLE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,553,096 | -18.2% | 575,067 | +3.9% | 0.04% | -12.8% |
| Q2 2023 | $14,128,689 | +44.4% | 553,632 | +20.3% | 0.05% | +38.2% |
| Q1 2023 | $9,786,859 | -13.1% | 460,125 | +20.9% | 0.03% | -17.1% |
| Q4 2022 | $11,264,428 | -41.0% | 380,555 | -53.7% | 0.04% | +7.9% |
| Q3 2022 | $19,102,486 | +22.9% | 821,280 | -11.3% | 0.04% | +31.0% |
| Q2 2022 | $15,539,593 | +21.9% | 926,054 | +218.8% | 0.03% | +61.1% |
| Q1 2022 | $12,747,746 | +44.2% | 290,508 | +100.0% | 0.02% | -21.7% |
| Q4 2021 | $8,841,000 | +7.0% | 145,252 | -26.9% | 0.02% | 0.0% |
| Q3 2021 | $8,263,000 | -31.1% | 198,673 | -49.7% | 0.02% | +35.3% |
| Q2 2021 | $11,992,000 | +103.0% | 395,020 | +99.7% | 0.02% | -5.6% |
| Q1 2021 | $5,908,000 | +127.0% | 197,799 | +36.4% | 0.02% | +125.0% |
| Q4 2020 | $2,603,000 | – | 144,997 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |